Company profile: Numerate
1.1 - Company Overview
Company description
- Provider of cloud-scale machine-learning-driven drug design and discovery, with a computational platform that predicts how potential drugs will behave in the lab and the body, combining data science, machine learning, cloud analytics, and medicinal chemistry.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Numerate
Refeyn
HQ: United Kingdom
Website
- Description: Provider of label-free single-molecule imaging and mass measurement solutions, including mass photometry for measuring single molecules in solution without labels; ready-to-use consumables to facilitate measurements with reduced sample preparation time; macro mass photometry for large viral vectors to characterize sample purity and stability; and KaritroMP to analyze individual particles by size and contrast.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Refeyn company profile →
BlinkBio
HQ: United States
Website
- Description: Provider of specialized bioorthogonal chemistries for the delivery of next-generation medicines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BlinkBio company profile →
StemoniX
HQ: United States
Website
- Description: Provider of stem cell–based, human-relevant in vitro platforms for drug discovery and toxicity testing. Products include NerveSim (3D peripheral nervous system model with nerve conduction and neurodegeneration metrics), BrainSim (3D brain organoid platform), and microBrain (human iPSC-derived CNS screening with functional cortical neuron–astrocyte networks). Founded in 2014, headquartered in Maple Grove, Minnesota.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full StemoniX company profile →
Lextox
HQ: United Kingdom
Website
- Description: Provider of hair drug and alcohol, blood alcohol, DNA, and SCRAM continuous alcohol testing for family law cases and child care proceedings. Operates a hair drug and alcohol testing laboratory and is a member of the SYNLAB Group. Customers can contact via phone, mail, and social media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lextox company profile →
Celltrio
HQ: United States
Website
- Description: Provider of cell culturing automation and biobanking solutions via RoboCell, a cell line automation platform for cell maintenance, culture and screening; Bioflow, software to define, schedule, execute and monitor workflows with real-time data tracking; and RoboStor, automated LN2 storage for biobanking and cryogenic applications, standalone or integrated with RoboCell.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celltrio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Numerate
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Numerate
2.2 - Growth funds investing in similar companies to Numerate
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Numerate
4.2 - Public trading comparable groups for Numerate
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →